[Clinical trial of the use of oleandomycin (for intravenous administration)].
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D007231:Infant, Newborn; D007239:Infections / Q000188:drug therapy*; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D009187:Myelitis / Q000188:drug therapy; D009827:Oleandomycin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000494:pharmacology; D010538:Peritonitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013492:Suppuration / Q000188:drug therapy
D002701:Chloramphenicol; D009827:Oleandomycin; D010118:Oxytetracycline; D013307:Streptomycin
Opyt klinicheskogo primeneniia oleandomitsina (dlia vnutrivennogo vvedeniia)